Chemosuppressive Field Trials in Thailand

II. The Suppression of Plasmodium falciparum and Plasmodium vivax Parasitemias by a Diformyldapsone-Pyrimethamine Combination

Eliot J. Pearlman U.S. Army Medical Component, SEATO, Medical Research Laboratories, Bangkok, Thailand

Search for other papers by Eliot J. Pearlman in
Current site
Google Scholar
PubMed
Close
,
Withoon Thiemanun U.S. Army Medical Component, SEATO, Medical Research Laboratories, Bangkok, Thailand

Search for other papers by Withoon Thiemanun in
Current site
Google Scholar
PubMed
Close
, and
Ben F. Castaneda U.S. Army Medical Component, SEATO, Medical Research Laboratories, Bangkok, Thailand

Search for other papers by Ben F. Castaneda in
Current site
Google Scholar
PubMed
Close
Restricted access

In an area of Thailand where chloroquine-resistant falciparum malaria is known to exist, a chemosuppressive field trial was undertaken to test the efficacy of the preparation diformyldapsone (DFD) combined with pyrimethamine (Py) in suppressing falciparum and vivax parasitemias. Six hundred and fifty-nine Thai villagers were randomly assigned to one of five treatment groups: DFD-Py; dapsone (DDS)-Py; DFD alone; Py alone; and placebo. Five hundred and ninety-three study subjects completed the 26-week trial. The combination DFD-Py given weekly was shown to be an effective chemosuppressive against both falciparum and vivax parasitmias, causing a more than fourfold reduction in falciparum and an approximately threefold reduction in vivax parasitemias; however, this combination was not more efficacious than DDS-Py for the chemosuppression of falciparum malaria. DFD alone was only moderately effective, while there was no difference in chemosuppression between Py alone and placebo.

Author Notes

Present address: Letterman Army Institute of Research, Presidio of San Francisco, California 94129.

Save